🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07642284
Recruiting Not applicable

Clinical Performance of AH Plus Jet® Root Canal Sealers in Single-cone Protocols

NCT07642284 · tracked via the Priya Life Science USA tracker
Sponsor
Dentsply Sirona Implants and Consumables
Phase
Not applicable
Started
2026-09-09
Last updated
2026-09-11

Condition(s) studied

Root Canal Treatment

Investigational drug(s) / intervention(s)

AH Plus Jet® Endodontic SealerAH Plus Jet® Root Canal Sealing Material

AH Plus Jet® Endodontic Sealer: AH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Endodontic Sealer has similar intended use and the same indications for use as the predicate Root Canal Sealer (AH Plus Jet® Root Canal Sealing Material). However, there are minor differences in the technological characteristics.

AH Plus Jet® Root Canal Sealing Material: AH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Root Canal Sealing Material is a predicate to AH Plus Jet® Endodontic Sealer.

Study summary

A prospective, parallel-group, randomised, post-market clinical follow-up investigation evaluating the performance and safety of the modified formula of the AH Plus Jet® Endodontic Sealer (also referred to as ES) and the predicate AH Plus Jet® Root Canal Sealing material (also referred to as RCS). Around 150 teeth will be randomly assigned to receive either ES or RCS root canal treatment using the single-cone technique. A maximum of 2 teeth per participant will be included and "tooth" will be considered the statistical unit and hence considered independent even if the teeth are in the same participant. Participants will be followed up for a period of 24 months to assess the outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Adult aged 18-75 at time of informed consent. 2. Subject willing to participate in the clinical investigation and able to understand the content of the clinical investigation. 3. Subject willing to return for follow-up visits. 4. Subject has signed and dated the informed consent form. 5. Subject in need of one or two primary root canal treatment on mature permanent anterior (incisor or canine) or premolar tooth. 6. Planned study tooth has a favorable prognosis for the next 2 years. Exclusion Criteria: 1. History of allergic reaction to epoxy resins or amines or any of the other product components. 2. Subject has significant systemic health issues or chronic conditions (American Society of Anesthesiologists (ASA) class 3-6). 3. Known pregnancy or is breastfeeding at time of enrolment or at the RCT visit. 4. Subject unlikely to comply with investigational procedures, as judged by the Investigator. 5. Sign of sinus tract or gingival swelling in the planned study position. 6. Previous enrolment in the present clinical investigation. 7. Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona personnel and the clinical investigation site). 8. Participation in another clinical investigation that may interfere with the present clinical investigation. 9. Subject experiencing an intraoperative condition that may interfere with the evaluation of the investigational root canal sealer.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
New York University College of Dentistry New York New York Recruiting

More Dentsply Sirona Implants and Consumables trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07642284 on ClinicalTrials.gov ↗ ← All trials in the USA